Treatment of ANCA-Associated Glomerulonephritis in a Patient with Bacteremia and Vertebral Osteomyelitis: A Challenging Clinical Dilemma

Introduction: ANCA-associated vasculitis (AAV) involves an autoimmune response that produces antibodies targeting neutrophil antigens, leading to necrotizing and crescentic glomerulonephritis. While modern immunosuppressive therapies have improved outcomes, infections remain a significant risk. Older age and high disease activity at diagnosis are critical prognostic factors. This case highlights the challenge of balancing immunosuppression with infection management. Case Description: A 77-year-old man with a history of anti-glomerular basement membrane disease leading to chronic kidney disease (CKD) stage 3a was admitted for a burn injury, which worsened his kidney function. He was readmitted with acute kidney injury (AKI) and diagnosed with microscopic polyangiitis and crescentic glomerulonephritis with IgA deposits. Despite treatment with Rituximab and high-dose corticosteroids, he developed Enterobacter Cloacae bacteremia and vertebral osteomyelitis. His condition further complicated with disseminated Herpes Zoster infection and progression to end-stage kidney disease (ESKD), requiring dialysis. He ultimately succumbed to refractory septic shock three months after diagnosis. Discussion: The treatment of ANCA-associated small vessel vasculitis and glomerulonephritis primarily involves high-dose corticosteroids and cyclophosphamide. However, balancing immunosuppression with infection risk is challenging, especially in elderly patients. Despite remission in the majority of patients, relapse is common, particularly in those with anti-PR3 positivity. This case underscores the need for accurate prognostic tools and strategies to mitigate infection risks while managing AAV. Lower dose steroid regimens and new agents like Avacopan may offer safer alternatives without compromising efficacy. Labs - 7/30/2023 7/29/2023 6/12/2023 Na 134 135 138 K 4.2 4.4 4.3 Cl 100 99 105 CO2 22 22 24 Anion Gap 12 14 9 BUN 54 56 36 Creatinine 6.15 5.91 1.62 eGFR 9 9 44 Calcium 8.4 8.1 8.5 Phosphorus 4.9 4.5

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.202446jsczw4
Citations
1
Primary Topic
Orthopedic Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment of ANCA-Associated Glomerulonephritis in a Patient with Bacteremia and Vertebral Osteomyelitis: A Challenging Clinical Dilemma

Abdullah Thayyil, Melissa L. Swee, Bahjat Azrieh
1 citations
Journal of the American Society of Nephrology
Orthopedic Infections and Treatments
0.57
article

Treatment of ANCA-Associated Glomerulonephritis in a Patient with Bacteremia and Vertebral Osteomyelitis: A Challenging Clinical Dilemma

Abdullah Thayyil, Melissa L. Swee, Bahjat Azrieh
article en
1 citations

Abstract

Introduction: ANCA-associated vasculitis (AAV) involves an autoimmune response that produces antibodies targeting neutrophil antigens, leading to necrotizing and crescentic glomerulonephritis. While modern immunosuppressive therapies have improved outcomes, infections remain a significant risk. Older age and high disease activity at diagnosis are critical prognostic factors. This case highlights the challenge of balancing immunosuppression with infection management. Case Description: A 77-year-old man with a history of anti-glomerular basement membrane disease leading to chronic kidney disease (CKD) stage 3a was admitted for a burn injury, which worsened his kidney function. He was readmitted with acute kidney injury (AKI) and diagnosed with microscopic polyangiitis and crescentic glomerulonephritis with IgA deposits. Despite treatment with Rituximab and high-dose corticosteroids, he developed Enterobacter Cloacae bacteremia and vertebral osteomyelitis. His condition further complicated with disseminated Herpes Zoster infection and progression to end-stage kidney disease (ESKD), requiring dialysis. He ultimately succumbed to refractory septic shock three months after diagnosis. Discussion: The treatment of ANCA-associated small vessel vasculitis and glomerulonephritis primarily involves high-dose corticosteroids and cyclophosphamide. However, balancing immunosuppression with infection risk is challenging, especially in elderly patients. Despite remission in the majority of patients, relapse is common, particularly in those with anti-PR3 positivity. This case underscores the need for accurate prognostic tools and strategies to mitigate infection risks while managing AAV. Lower dose steroid regimens and new agents like Avacopan may offer safer alternatives without compromising efficacy. Labs - 7/30/2023 7/29/2023 6/12/2023 Na 134 135 138 K 4.2 4.4 4.3 Cl 100 99 105 CO2 22 22 24 Anion Gap 12 14 9 BUN 54 56 36 Creatinine 6.15 5.91 1.62 eGFR 9 9 44 Calcium 8.4 8.1 8.5 Phosphorus 4.9 4.5

Journal of the American Society of NephrologyVol. 35(10S)
University of Iowa Hospitals and Clinics (US)
Good health and well-being
Openalex Percentile: Top 28%
Orthopedic Infections and Treatments
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.